Levetiracetam Aurobindo

Levetiracetam, the active ingredient in Levetiracetam Aurobindo, is an anticonvulsant presented as an oral dosage form for oral use. It is employed to treat various seizure types in patients with epilepsy, including partial, generalized tonic‑clonic, and myoclonic seizures.

GNH USA supplies Levetiracetam Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing quality‑assured products that meet EU regulatory standards.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain, helping control seizure activity.

Partial seizures: decreases frequency and severity of focal seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: reduces rapid, involuntary muscle jerks.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness - Fatigue - Headache - Somnolence - Nausea - Irritability

Serious or Rare Side Effects: - Severe allergic reactions (e.g., Stevens‑Johnson syndrome) - Mood changes including depression or suicidal thoughts - Hematologic abnormalities (e.g., neutropenia) - Severe skin rash - Hepatic dysfunction - Respiratory depression when combined with other CNS depressants

Before initiating therapy, consider the following safety measures.

Renal impairment: dose adjustment may be required based on renal function. Mood monitoring: observe for depression, anxiety, or suicidal ideation. Drug discontinuation: avoid abrupt cessation to reduce seizure recurrence. Pregnancy: risk unknown; use only if benefit outweighs potential risk. Drug interactions: review concomitant medications for potential interactions. Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with several medicines; awareness helps maintain therapeutic effectiveness.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenytoin: can reduce levetiracetam levels. - Rifampin: induces metabolism, decreasing drug exposure.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations. - Other CNS depressants: additive sedation or respiratory depression. - Alcohol: enhances central nervous system effects.